Eli Lilly Tries To Nix Claims In Mounjaro Failure-To-Warn Suit
By Collin Krabbe ( October 30, 2023, 5:59 PM EDT) -- The maker of a medication for treating diabetes says a suit over its alleged failure to warn a patient about the risk of severe stomach issues is stymied by clear disclosure on the label and a general knowledge of the risks, arguing the plaintiff made a "scattershot pleading" that fails to specify the actions of each defendant....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.